Product Information

CLINDAMYCIN-BENZOYL PEROX 1-5% is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.5646 per GM under NDC 68462048627. Its NADAC has been published 387 times since Jun 26, 2019.

FDA first approved this application on Mar 14, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLINDAMYCIN-BENZOYL PEROX 1-5%

clindamycin and benzoyl peroxide
$0.5646per GM

Strength

50; 10 mg/g; mg/g

NDC

68462048627

Classification

Generic

Dosage Form

GEL

Route

TOPICAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA209252

FDA Approved

3/14/2019

TE Code

AB

On Market Since

3/14/2019

Pharmacological Classes

Decreased Sebaceous Gland Activity
Lincosamide Antibacterial
Lincosamides
Neuromuscular Blockade

Price Statistics

The NADAC for CLINDAMYCIN-BENZOYL PEROX 1-5% has been published 387 times since Jun 26, 2019, and over the history we have for it it has declined 72.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5646 per GM
All-time high$2.2529 (Jul 15, 2020)
All-time low$0.4212 (Nov 20, 2024)
52-week high$0.6611
52-week low$0.4647
Median price$0.7930
Average price$1.0038
Largest weekly change+55.5% (Aug 21, 2024)
Weeks tracked387
Tracking sinceJun 26, 2019

Price History

1W

+4.7%

1M

+12.8%

3M

+21.2%

6M

+3.8%

1Y

-14.6%

3Y

-39.9%

5Y

-28.1%

All

-72.7%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLINDAMYCIN-BENZOYL PEROX 1-5%?

The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN-BENZOYL PEROX 1-5%, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.5646 per GM (NDC 68462048627), effective Nov 18, 2026.

How has the price of CLINDAMYCIN-BENZOYL PEROX 1-5% changed over time?

Over the history we have for it, the NADAC for CLINDAMYCIN-BENZOYL PEROX 1-5% has declined 72.7%. It has been tracked across 387 weekly CMS publications since Jun 26, 2019.

What are the highest and lowest recorded NADAC prices for CLINDAMYCIN-BENZOYL PEROX 1-5%?

Since Jun 26, 2019, the NADAC for CLINDAMYCIN-BENZOYL PEROX 1-5% has ranged from a low of $0.4212 (Nov 20, 2024) to a high of $2.2529 (Jul 15, 2020), with a median of $0.7930 per GM.

Are there cheaper alternatives to CLINDAMYCIN-BENZOYL PEROX 1-5%?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLINDAMYCIN-BENZOYL PEROX 1-5% in a comparable dosage form, but none are currently priced below it.

Who manufactures CLINDAMYCIN-BENZOYL PEROX 1-5%?

CLINDAMYCIN-BENZOYL PEROX 1-5% (NDC 68462048627) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.